NCT06182358: An ongoing trial by Tarsus Pharmaceuticals, Inc.
This trial is ongoing. It must report results 1 month, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06182358 |
|---|---|
| Title | Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 27, 2023 |
| Completion date | Jan. 27, 2025 |
| Required reporting date | Jan. 27, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |